NOVIMMUNE
USPTO Trademark Record · Serial No. 75907462
Trademark details
It was initially claimed by NovImmune SA on 20000201.
That brand applies to the following goods and services:Chemicals for use in the manufacture of pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, including [ superantigens, ] small molecular weight compounds, polypeptides and monoclonal antibodies, Pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, namely, superantigens, small molecular weight compounds, polypeptides and monoclonal antibodies; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases, inflammation and for use during transplantation, including diabetes, multiple sclerosis, rheumatoid arthritis and lupus, and for immuno-modulation, namely, immuno-suppression; pharmaceuti, legal services; scientific research; chemical research; consulting in the pharmaceutical and biomedical fields.
Currently that trademark is represented by trademark attorney(s): Duane M. Byers.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the NOVIMMUNE trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
